Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis

Jeremy D. Waight, Colleen Netherby, Mary L. Hensen, Austin Miller, Qiang Hu, Song Liu, Paul N. Bogner, Matthew R. Farren, Kelvin P. Lee, Kebin Liu, Scott I. Abrams

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations produced in diverse pathologies, including neoplasia. Because MDSCs can impair antitumor immunity, these cells have emerged as a significant barrier to cancer therapy. Although much research has focused on how MDSCs promote tumor progression, it remains unclear how MDSCs develop and why the MDSC response is heavily granulocytic. Given that MDSCs are a manifestation of aberrant myelopoiesis, we hypothesized that MDSCs arise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral transcriptional component of myeloid differentiation and lineage commitment. Overall, we demonstrated that (a) Irf8-deficient mice generated myeloid populations highly homologous to tumor-induced MDSCs with respect to phenotype, function, and gene expression profiles; (b) IRF-8 overexpression in mice attenuated MDSC accumulation and enhanced immunotherapeutic efficacy; (c) the MDSC-inducing factors G-CSF and GM-CSF facilitated IRF-8 downregulation via STAT3- and STAT5-dependent pathways; and (d) IRF-8 levels in MDSCs of breast cancer patients declined with increasing MDSC frequency, implicating IRF-8 as a negative regulator in human MDSC biology. Together, our results reveal a previously unrecognized role for IRF-8 expression in MDSC subset development, which may provide new avenues to target MDSCs in neoplasia.

Original languageEnglish (US)
Pages (from-to)4464-4478
Number of pages15
JournalJournal of Clinical Investigation
Volume123
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Myeloid-Derived Suppressor Cells
interferon regulatory factor-8
Neoplasms
Granulocyte-Macrophage Colony-Stimulating Factor
Myelopoiesis
Granulocyte Colony-Stimulating Factor
Transcriptome
Population
Cell Biology
Immunity
Down-Regulation
Pathology
Breast Neoplasms
Phenotype
Research
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Waight, J. D., Netherby, C., Hensen, M. L., Miller, A., Hu, Q., Liu, S., ... Abrams, S. I. (2013). Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. Journal of Clinical Investigation, 123(10), 4464-4478. https://doi.org/10.1172/JCI68189

Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. / Waight, Jeremy D.; Netherby, Colleen; Hensen, Mary L.; Miller, Austin; Hu, Qiang; Liu, Song; Bogner, Paul N.; Farren, Matthew R.; Lee, Kelvin P.; Liu, Kebin; Abrams, Scott I.

In: Journal of Clinical Investigation, Vol. 123, No. 10, 01.10.2013, p. 4464-4478.

Research output: Contribution to journalArticle

Waight, JD, Netherby, C, Hensen, ML, Miller, A, Hu, Q, Liu, S, Bogner, PN, Farren, MR, Lee, KP, Liu, K & Abrams, SI 2013, 'Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis', Journal of Clinical Investigation, vol. 123, no. 10, pp. 4464-4478. https://doi.org/10.1172/JCI68189
Waight JD, Netherby C, Hensen ML, Miller A, Hu Q, Liu S et al. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. Journal of Clinical Investigation. 2013 Oct 1;123(10):4464-4478. https://doi.org/10.1172/JCI68189
Waight, Jeremy D. ; Netherby, Colleen ; Hensen, Mary L. ; Miller, Austin ; Hu, Qiang ; Liu, Song ; Bogner, Paul N. ; Farren, Matthew R. ; Lee, Kelvin P. ; Liu, Kebin ; Abrams, Scott I. / Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. In: Journal of Clinical Investigation. 2013 ; Vol. 123, No. 10. pp. 4464-4478.
@article{767c42b1936444ae9db4a03adb38e96a,
title = "Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis",
abstract = "Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations produced in diverse pathologies, including neoplasia. Because MDSCs can impair antitumor immunity, these cells have emerged as a significant barrier to cancer therapy. Although much research has focused on how MDSCs promote tumor progression, it remains unclear how MDSCs develop and why the MDSC response is heavily granulocytic. Given that MDSCs are a manifestation of aberrant myelopoiesis, we hypothesized that MDSCs arise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral transcriptional component of myeloid differentiation and lineage commitment. Overall, we demonstrated that (a) Irf8-deficient mice generated myeloid populations highly homologous to tumor-induced MDSCs with respect to phenotype, function, and gene expression profiles; (b) IRF-8 overexpression in mice attenuated MDSC accumulation and enhanced immunotherapeutic efficacy; (c) the MDSC-inducing factors G-CSF and GM-CSF facilitated IRF-8 downregulation via STAT3- and STAT5-dependent pathways; and (d) IRF-8 levels in MDSCs of breast cancer patients declined with increasing MDSC frequency, implicating IRF-8 as a negative regulator in human MDSC biology. Together, our results reveal a previously unrecognized role for IRF-8 expression in MDSC subset development, which may provide new avenues to target MDSCs in neoplasia.",
author = "Waight, {Jeremy D.} and Colleen Netherby and Hensen, {Mary L.} and Austin Miller and Qiang Hu and Song Liu and Bogner, {Paul N.} and Farren, {Matthew R.} and Lee, {Kelvin P.} and Kebin Liu and Abrams, {Scott I.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1172/JCI68189",
language = "English (US)",
volume = "123",
pages = "4464--4478",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis

AU - Waight, Jeremy D.

AU - Netherby, Colleen

AU - Hensen, Mary L.

AU - Miller, Austin

AU - Hu, Qiang

AU - Liu, Song

AU - Bogner, Paul N.

AU - Farren, Matthew R.

AU - Lee, Kelvin P.

AU - Liu, Kebin

AU - Abrams, Scott I.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations produced in diverse pathologies, including neoplasia. Because MDSCs can impair antitumor immunity, these cells have emerged as a significant barrier to cancer therapy. Although much research has focused on how MDSCs promote tumor progression, it remains unclear how MDSCs develop and why the MDSC response is heavily granulocytic. Given that MDSCs are a manifestation of aberrant myelopoiesis, we hypothesized that MDSCs arise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral transcriptional component of myeloid differentiation and lineage commitment. Overall, we demonstrated that (a) Irf8-deficient mice generated myeloid populations highly homologous to tumor-induced MDSCs with respect to phenotype, function, and gene expression profiles; (b) IRF-8 overexpression in mice attenuated MDSC accumulation and enhanced immunotherapeutic efficacy; (c) the MDSC-inducing factors G-CSF and GM-CSF facilitated IRF-8 downregulation via STAT3- and STAT5-dependent pathways; and (d) IRF-8 levels in MDSCs of breast cancer patients declined with increasing MDSC frequency, implicating IRF-8 as a negative regulator in human MDSC biology. Together, our results reveal a previously unrecognized role for IRF-8 expression in MDSC subset development, which may provide new avenues to target MDSCs in neoplasia.

AB - Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations produced in diverse pathologies, including neoplasia. Because MDSCs can impair antitumor immunity, these cells have emerged as a significant barrier to cancer therapy. Although much research has focused on how MDSCs promote tumor progression, it remains unclear how MDSCs develop and why the MDSC response is heavily granulocytic. Given that MDSCs are a manifestation of aberrant myelopoiesis, we hypothesized that MDSCs arise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral transcriptional component of myeloid differentiation and lineage commitment. Overall, we demonstrated that (a) Irf8-deficient mice generated myeloid populations highly homologous to tumor-induced MDSCs with respect to phenotype, function, and gene expression profiles; (b) IRF-8 overexpression in mice attenuated MDSC accumulation and enhanced immunotherapeutic efficacy; (c) the MDSC-inducing factors G-CSF and GM-CSF facilitated IRF-8 downregulation via STAT3- and STAT5-dependent pathways; and (d) IRF-8 levels in MDSCs of breast cancer patients declined with increasing MDSC frequency, implicating IRF-8 as a negative regulator in human MDSC biology. Together, our results reveal a previously unrecognized role for IRF-8 expression in MDSC subset development, which may provide new avenues to target MDSCs in neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=84885029080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885029080&partnerID=8YFLogxK

U2 - 10.1172/JCI68189

DO - 10.1172/JCI68189

M3 - Article

VL - 123

SP - 4464

EP - 4478

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -